Multitarget inhibitors exhibit significant advantages in reducing the risk of drug resistance, enhancing therapeutic efficacy, and minimizing dosage, outperforming multicomponent combination drugs. On the basis of glycoside hydrolase family 18 (GH18) chitinases and GH20 β-